Reduction of glycemic variability with Degludec insulin in patients with unstable diabetes

INTRODUCTION: Degludec (IDeg) is an ultralong-acting insulin, with stable pharmacodynamic profile which leads to lower fluctuations in glucose levels. The effect of IDeg has not been specifically assessed in patients with unstable diabetes, defined as increased glycemic variability (GV). METHODS: A...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Clin Transl Endocrinol
Hoofdauteurs: Henao-Carrillo, Diana Cristina, Muñoz, Oscar M., Gómez, Ana M., Rondón, Martín, Colón, Christian, Chica, L., Rubio, Claudia, León-Vargas, Fabián, Calvachi, Maria Alejandra, Perea, Ana María
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Elsevier 2018
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5992319/
https://ncbi.nlm.nih.gov/pubmed/29892561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcte.2018.03.003
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items